Completed PHASE4 INTERVENTIONAL 2-arm NCT05446493

Serum YKL-40 Level and Platelets Indices Among Patients With Diabetic Erectile Dysfunction

Assessment of Serum YKL-40 Level and Platelets Indices Among Patients With Diabetic Erectile Dysfunction

Sponsor: Aswan University

Conditions Erectile Dysfunction Erectile Dysfunction With Diabetes Mellitus

Updated 4 times since 2022 Last updated: Jul 5, 2022 Started: Apr 1, 2019 Primary completion: Mar 15, 2021 Completion: Jan 5, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05446493, this PHASE4 trial focuses on Erectile Dysfunction and Erectile Dysfunction With Diabetes Mellitus and remains completed. Sponsored by Aswan University, it has been updated 4 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Sep 2022 — Jul 2024 [monthly]

Completed PHASE4

First recorded

Apr 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aswan University

Data source: Aswan University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aswān, Egypt